Can a transplant drug boost heart health in the elderly?
NCT ID NCT04742777
First seen Nov 01, 2025 · Last updated Jun 05, 2026 · Updated 29 times
Summary
This study looked at whether rapamycin, a drug used to prevent transplant rejection, can improve heart function in healthy adults aged 70-95. Researchers used MRI scans to measure changes in heart pumping and blood vessel flexibility after 8 weeks of treatment. The goal was to see if this drug could help manage age-related declines in heart health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Audie L. Murphy Memorial Veterans Hospital
San Antonio, Texas, 78229, United States
-
The University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.